Qsymia

(Newser) - Just a few years ago, a drug company CEO predicted anti-obesity pills could rival the sales of drugs like Lipitor. Instead, the first prescription diet pill to arrive in 13 years is barely selling, the New York Times reports. Qsymia maker Vivus spent $45 million to promote the drug in...

(Newser) - After 13 years without approving a new weight-loss drug, the FDA has now approved two within three weeks. After June's approval of Belviq , the FDA yesterday approved Qsymia, which used to be called Qnexa ; both drugs had previously been rejected. In studies, Qsymia resulted in the greater weight loss:...